Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
12.53
+1.04 (9.05%)
At close: Jun 3, 2026, 4:00 PM EDT
12.56
+0.03 (0.24%)
After-hours: Jun 3, 2026, 4:31 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $230.5 million as of June 3, 2026. Its market cap has increased by 170.59% in one year.
Market Cap
230.50M
Enterprise Value
229.89M
1-Year Change
170.59%
Ranking
Category
Stock Price
$12.53
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $230.50M, a decrease of -26.17%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 211.37M | 51.95% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 230.14M |
| Alector | 229.82M |
| Orchestra BioMed Holdings | 229.34M |
| Voyager Therapeutics | 229.00M |
| Minerva Neurosciences | 225.49M |
| Nkarta | 224.65M |
| Whitehawk Therapeutics | 221.93M |
| Karyopharm Therapeutics | 221.45M |